Sarah A. Best

1.5k total citations
39 papers, 980 citations indexed

About

Sarah A. Best is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Sarah A. Best has authored 39 papers receiving a total of 980 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Genetics. Recurrent topics in Sarah A. Best's work include Glioma Diagnosis and Treatment (8 papers), Cancer Cells and Metastasis (5 papers) and Single-cell and spatial transcriptomics (4 papers). Sarah A. Best is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Cancer Cells and Metastasis (5 papers) and Single-cell and spatial transcriptomics (4 papers). Sarah A. Best collaborates with scholars based in Australia, United States and Austria. Sarah A. Best's co-authors include Ariena Kersbergen, Matthew E. Ritchie, Vivek Rathi, Jane E. Visvader, David P. De Souza, Malcolm J. McConville, Saravanan Dayalan, Antonia N. Policheni, Dedreia Tull and Daniel H.D. Gray and has published in prestigious journals such as Nature Communications, Genes & Development and Nature Cell Biology.

In The Last Decade

Sarah A. Best

35 papers receiving 968 citations

Peers

Countries citing papers authored by Sarah A. Best

Since Specialization

Citations

This map shows the geographic impact of Sarah A. Best's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah A. Best with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah A. Best more than expected).

Fields of papers citing papers by Sarah A. Best

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah A. Best. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah A. Best. The network helps show where Sarah A. Best may publish in the future.

Co-authorship network of co-authors of Sarah A. Best

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah A. Best. A scholar is included among the top collaborators of Sarah A. Best based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah A. Best. Sarah A. Best is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Spatial omics shed light on the tumour organisation of glioblastoma 2025 ·Seminars in Cell and Developmental Biology ·James R. Whittle, Jurgen Kriel, (unknown), (unknown), Joel J D Moffet, M A Spiteri, Sarah A. Best, Saskia Freytag	4
2	PRMT1 Inhibition Targets BNC1-Dependent Proliferation in Squamous Cell Carcinoma 2025 ·Journal of Investigative Dermatology ·(unknown), Bethany L. Patenall, Sandra L. King, (unknown), Diana Wang, Sarah A. Best, Joo Yeon Ko, Shuyun Xu, Rui Fang, (unknown), Chrysalyne D. Schmults, Steven R. Barthel, Christine G. Lian, Matthew R. Ramsey	0
3	Materializing Magic: How the Witches of Instagram Make the Invisible Visible Through Digital Photography and Editing Techniques 2024 ·Sarah A. Best	0
4	A perioperative study of Safusidenib in patients with IDH1 -mutated glioma 2024 ·Future Oncology ·(unknown), Monique Topp, Mark Rosenthal, (unknown), Saskia Freytag, Sarah A. Best, James R. Whittle, Katharine J. Drummond	1
5	443O A perioperative study of safusidenib in patients with IDH1 mutated glioma 2024 ·Annals of Oncology ·James R. Whittle, Mark Rosenthal, M A Spiteri, Sarah Cain, (unknown), (unknown), Jordan Jones, (unknown), (unknown), (unknown), R. L. Tobler, (unknown), (unknown), Elaine Lui, Brunda Nijagal, Sean M. Grimmond, Sarah A. Best, Saskia Freytag, Katharine J. Drummond	0
6	From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress 2023 ·Signal Transduction and Targeted Therapy ·(unknown), Misty R. Jenkins, Sarah A. Best, Saskia Freytag, (unknown), Jeff Holst, Raelene Endersby, Terrance G. Johns	53
7	Matrix Selection for the Visualization of Small Molecules and Lipids in Brain Tumors Using Untargeted MALDI-TOF Mass Spectrometry Imaging 2023 ·Metabolites ·(unknown), (unknown), Vinod K. Narayana, (unknown), (unknown), (unknown), Brunda Nijagal, (unknown), David P. De Souza, Malcolm J. McConville, James R. Whittle, Sarah A. Best, Saskia Freytag	7
8	Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer 2022 ·Cell Metabolism ·Sarah A. Best, Patrick M. Gubser, Shalini Sethumadhavan, Ariena Kersbergen, Yashira L. Negrón Abril, Joshua E. Goldford, Katherine Sellers, Waruni Abeysekera, Alexandra L. Garnham, (unknown), Clare E. Weeden, Dovile Anderson, David Pirman, Thomas P. Roddy, Darren J. Creek, Axel Kallies, Gillian A. Kingsbury, (unknown)	115
9	BCKDK alters the metabolism of non-small cell lung cancer 2021 ·Translational Lung Cancer Research ·Yanhui Wang, (unknown), Wenna Jiang, Duo Zuo, Xia Wang, Yu Jin, Lu Qiao, (unknown), (unknown), Daphne W. Dumoulin, Wolfram C. M. Dempke, Sarah A. Best, Li Ren	28
10	Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis 2020 ·Cell Death and Disease ·Sarah A. Best, Cassandra J. Vandenberg, Etna Abad, Lachlan Whitehead, (unknown), (unknown), Margs S. Brennan, Andreas Strasser, Marco J. Herold, (unknown), Ana Janic	9
11	Harnessing Natural Killer Immunity in Metastatic SCLC 2020 ·Journal of Thoracic Oncology ·Sarah A. Best, (unknown), Fernando Souza-Fonseca-Guimarães, Joseph Cursons, Ariena Kersbergen, Xueyi Dong, Jai Rautela, (unknown), Matthew E. Ritchie, Melissa J. Davis, Tracy L. Leong, Louis Irving, Daniel Steinfort, Nicholas D. Huntington, (unknown)	61
12	Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma 2019 ·Nature Communications ·Sarah A. Best, (unknown), Ariena Kersbergen, Xueyi Dong, Ji‐Ying Song, Yi Xie, Boris Reljić, (unknown), James E. Vince, Vivek Rathi, Gavin Wright, Matthew E. Ritchie, (unknown)	71
13	Lung morphogenesis is orchestrated through Grainyhead-like 2 (Grhl2) transcriptional programs 2018 ·Developmental Biology ·Ariena Kersbergen, Sarah A. Best, Sebastian Dworkin, Casey Ah-Cann, (unknown), Marie-Liesse Asselin-Labat, Matthew E. Ritchie, Stephen M. Jane, (unknown)	16
14	Combining Cell Type-Restricted Adenoviral Targeting with Immunostaining and Flow Cytometry to Identify Cells-of-Origin of Lung Cancer 2018 ·Methods in molecular biology ·Sarah A. Best, Ariena Kersbergen, Marie-Liesse Asselin-Labat, (unknown)	7
15	Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment 2018 ·Cell Metabolism ·Sarah A. Best, David P. De Souza, Ariena Kersbergen, Antonia N. Policheni, Saravanan Dayalan, Dedreia Tull, Vivek Rathi, Daniel H.D. Gray, Matthew E. Ritchie, Malcolm J. McConville, (unknown)	151
16	Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia 2015 ·Leukemia ·Matthew T. Witkowski, Luigi Cimmino, Yifang Hu, Thomas Trimarchi, Hiromi Tagoh, Mark McKenzie, Sarah A. Best, Laura Tuohey, Tracy A. Willson, Stephen L. Nutt, Meinrad Busslinger, Iannis Aifantis, Gordon K. Smyth, Ross A. Dickins	24
17	EGF-mediated induction of Mcl-1 at the switch to lactation is essential for alveolar cell survival 2015 ·Nature Cell Biology ·Nai Yang Fu, Anne C. Rios, Bhupinder Pal, (unknown), Aaron T. L. Lun, Kevin Liu, Tamara Beck, Sarah A. Best, François Vaillant, Philippe Bouillet, Andreas Strasser, Thomas Preiß, Gordon K. Smyth, Geoffrey J. Lindeman, Jane E. Visvader	55
18	Runx2 Is a Novel Regulator of Mammary Epithelial Cell Fate in Development and Breast Cancer 2014 ·Cancer Research ·Thomas W. Owens, (unknown), Sarah A. Best, (unknown), (unknown), Alison Ferguson, Paul Shore, Alexander Swarbrick, Christopher J. Ormandy, Peter T. Simpson, Jason S. Carroll, Jane E. Visvader, Matthew J. Naylor	60
19	PAX5 loss imposes a reversible differentiation block in b-progenitor acute lymphoblastic leukemia 2014 ·Experimental Hematology ·Grace Liu, Luisa Cimmino, Julian Jude, Yifang Hu, Mutlu Kartal, Matthew T. Witkowski, Mark McKenzie, Sarah A. Best, Laura Tuohey, Charles G. Mullighan, Michael A. Farrar, Stephen L. Nutt, Gordon K. Smyth, Johannes Zuber, Ross A. Dickins	3
20	Tissue Compression Analysis for Magnetically Anchored Cautery Dissector During Single-Site Laparoscopic Cholecystectomy 2011 ·Journal of Gastrointestinal Surgery ·(unknown), Wareef Kabbani, (unknown), Sarah A. Best, Deborah C. Hogg, Jeffrey A. Cadeddu, Richard Bergs, (unknown), Raúl Fernández, Daniel J. Scott	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact